Loading...
Loading...
Among the 4 tracked institutional investors we monitor, ABVC (ABVC BIOPHARMA INC) is held with a combined value of $830.94K across 512,279 shares. The largest holder is VANGUARD GROUP INC with a position worth $613.31K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund reduced its position.
Total Institutional Value
$830.94K
Total Shares Held
512,279
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $613.31K | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $92.26K | 0.00% | -16.8% |
| 3 | STATE STREET CORP | $70.62K | 0.00% | - |
| 4 | BlackRock, Inc. | $54.75K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of ABVC with a position worth $613.31K, representing 0.00% of their portfolio. In total, 4 institutional investors hold ABVC with a combined value of $830.94K.
In the most recent quarter, 1 fund opened a new position in ABVC. Additionally, 1 reduced their positions.
Institutional investors hold $830.94K worth of ABVC stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $613.31K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ABVC, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ABVC positions.